Insider Trading July 24, 2026 05:46 AM

Rhinebeck Bancorp Director Nancy Patzwahl Acquires $298,500 in Stock Amid Corporate Conversion

Insider buying follows a significant 27% weekly decline in shares, as the bank navigates its transition from a mutual holding company to a fully public entity.

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
RBKB

Nancy Koskey Patzwahl, a director at Rhinebeck Bancorp, Inc. (NASDAQ:RBKB), executed a substantial purchase of the company's common stock on July 22, 2026. The transaction involves the acquisition of 25,000 shares at $11.94 per share, bringing her total beneficial ownership to 27,270 shares. This insider activity occurs against a backdrop of a 27% stock price drop over the preceding week, with the share price trading near its 52-week low of $9.41. Concurrently, Rhinebeck Bancorp is undergoing a critical structural transformation, converting from a mutual holding company to a fully public stock holding company. This process includes the approval of the conversion by stockholders and depositors, the initiation of a stock offering of up to 8,912,500 shares at $10.00 per share, and the engagement of Keefe, Bruyette & Woods, Inc. (KBW) as the financial advisor and marketing agent.

Rhinebeck Bancorp Director Nancy Patzwahl Acquires $298,500 in Stock Amid Corporate Conversion
RBKB
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Nancy Koskey Patzwahl, a director at Rhinebeck Bancorp, Inc. (NASDAQ:RBKB), purchased 25,000 shares at $11.94 per share on July 22, 2026, bringing her total beneficial ownership to 27,270 shares.
  • The stock dropped 27% over the past week, trading near its 52-week low of $9.41, while trading at a P/E ratio of 13.36 according to InvestingPro analysis.
  • Rhinebeck Bancorp is converting from a mutual holding company to a fully public stock holding company, with stockholders and depositors approving the conversion, pending regulatory approvals and the sale of at least 6,587,500 shares.

Nancy Koskey Patzwahl, serving as a director at Rhinebeck Bancorp, Inc. (NASDAQ:RBKB), has executed a significant acquisition of the company's equity. On July 22, 2026, Ms. Patzwahl purchased 25,000 shares of Rhinebeck Bancorp common stock at a price of $11.94 per share, resulting in a total transaction value of $298,500. This purchase increases her beneficial ownership to a total of 27,270 shares. A portion of these holdings consists of restricted stock that vests at a rate of 33 1/3% per year, commencing on May 26, 2027.

The timing of this insider acquisition is notable given the recent performance of RBKB shares. The stock experienced a 27% decline over the prior week, trading near its 52-week low of $9.41. According to InvestingPro analysis, the stock appears undervalued at current levels, trading at a P/E ratio of 13.36 while the company remains profitable.

Concurrently, Rhinebeck Bancorp is advancing through a major corporate restructuring. Stockholders and depositors have approved the conversion of Rhinebeck Bancorp, MHC from a mutual holding company to a fully public stock holding company structure. This conversion remains pending final regulatory approvals and the sale of at least 6,587,500 shares of common stock.

As part of this transition, Rhinebeck Bancorp has launched a stock offering of up to 8,912,500 shares at $10.00 per share. The offering initially targets eligible depositors and the bank's tax-qualified employee benefit plans. Any remaining shares may be offered to the general public, with priority given to residents of certain New York counties.

To support this offering, Rhinebeck Bancorp entered into an agreement with Keefe, Bruyette & Woods, Inc. (KBW). KBW will serve as the financial advisor and marketing agent, receiving a management fee of $50,000 and a success fee based on the aggregate proceeds. These developments mark a critical phase in Rhinebeck Bancorp's transition to a fully public entity.

Risks

  • The conversion to a fully public stock holding company structure is pending final regulatory approvals and the sale of at least 6,587,500 shares of common stock.
  • The stock offering may be prioritized for residents of certain New York counties, potentially limiting the investor base for any remaining shares offered to the general public.

More from Insider Trading

Rani Therapeutics Director Mir A Imran Acquires $24,839 in Stock Amid Clinical and Corporate Developments Jul 24, 2026 Cytokinetics EVP Fady Malik Sells Stock Amid Myqorzo Launch Momentum Jul 24, 2026 Acrivon Therapeutics CLO Mary Miller Sells $1,008 in Company Stock Jul 24, 2026 Kaltura Officer Eynav Azaria Executes $8,971 Stock Sale Under Pre-Arranged Plan Jul 24, 2026 Rhinebeck Bancorp Director Loughlin Acquires $149,120 in Stock Amid Structural Transition Jul 24, 2026